Expression of CSE in lung cancer tissues and discussions of CSE with clinical relevant factors
BAO Wen-hua1;ZHANG Li-min2;YAN Hong-e1;YANG Xiao-dong1 1.Department of Respiration;First Affiliated Hospital;Jiamusi University;Jiamusi 154003;P.R.China 2.Department of Internal Medicine;Central Hospital of Jiamusi;Jiamusi 154002;P.R.China

..............page:1608-1610

Research advance on β-tubulin related chemoresistance to paclitaxel drugs in lung cancer
LIANG Nai-xin;YANG Hua-xia;ZHANG Xue-fang;LI Shan-qing Department of Thoracic Surgery;Peking Union Medical College;Peking Union Hospital;Chinese Academy of Medical Sciences;Beijing;100730;P.R.China

..............page:1656-1660

Application sequential chemotherapy with taxol plus cisplatin and three-dimensional conformal radiation therapy in esophageal cancer
XUE Zhi-dong;WU Zheng-dong Department of Oncology;People’s Hospital of Taizhou City;Taizhou 225300;P.R.China

..............page:1646-1648

TS-1 combined with three-dimensional conformal radiotherapy for treatment of advanced esophageal cancer
YUAN Xin;TONG Jian-dong;YIN Xu-dong;XUE Jin-jun;WANG Rui Department of Oncology;First Hospital of Yangzhou;Yangzhou 225000;P.R.China

..............page:1644-1645,1648

Systematic review on Yanshu injection plus NP for terminal NSCLC
MA Ye-lin1;CHEN Liang-liang2 1.First Clinical College;Zhejiang University of Traditional Chinese Medicine;Hangzhou 310053;P.R.China 2.Department of Medical Oncology;Zhejiang Hospital of Traditional Chinese Medicine;Hangzhou 310006;P.R.China

..............page:1611-1615

Randomized clinical trail of three-dimension conformal radiotherapy combined with erlotinib or concurrent chemotherapy in treatment locally advanced non-small cell lung cancer
YUE Yang-jun1;LI Yun-sheng2;LI Sha1;WEI Shi-hua1;ZHU Xiang-hui1;TIAN Zhong-ze1 1.Department of Radiation Oncology;PLA Lanzhou Military Region General Hospital;Lanzhou 730050;P.R.China 2.Department of Respiratory Medicine;Pulmonary Hospital of Lanzhou;Lanzhou 730046;P.R.China

..............page:1628-1631

Clinical research of weekly paclitaxel concurrent radiochemotherapy for advanced esophageal cancer
LI Feng;ZHOU Yuan;ZHANG Li-cheng;WEI Hong-mei;GUO Shuang-shuang;MA Wen-jing Department of Oncology;No.88 Hospital of PLA Jinan Military Area Command;Taian 271000;P.R.China

..............page:1635-1638

Predicting values of cumulative pulmonary score for risk of respiratory failure in lung cancer patients with impaired pulmonary function udergoing thoractomy
FANG Yi1;MA Gang1;LOU Ning1;CHEN Guan-xuan1;GUAN Shu-fang1;ZHAO Qing-yu1;AN Sheng-li2 1.Cancer Center;Sun Yat-sen University;State Key Laboratory of Oncology in Southern China;Guangzhou;510060;P.R.China 2.Department of Biostatistics;Southern Medical University;Guangzhou;510515;P.R.China

..............page:1624-1627

Clinical trial/study of nedaplatin in advanced non-small cell lung cancer
CAI Jun;HU Yan;LI Jing-jing;ZHOU Qiong;FU Guo-quan;LI Shuang;JIANG Dai-wen;YANG Ji-yuan Department of Oncology;First Affiliated Hospital;Yangtze University;Jingzhou 434000;P.R.China

..............page:1632-1634

Comparison of the different planning target volumes defined basing on three-dimensional CT and four-dimensional CT images for liver cancer
LI Feng-xiang;LI Jian-bin;XING Jun;ZHANG Ying-jie;XU Min;WANG Su-zhen;SHANG Dong-ping;LIU Tong-hai Shandong Cancer Hospital and Institute;Jinan 250117;P.R.China

..............page:1639-1643

yuan fa shi guan xiao xi bao ai shu qian you dao hua liao yi li bing wen xian fu xi
qian peng fei li hong sheng he wei xing wang bo

..............page:1649-1650

Coexpression of Leptin and apotosis modulators in breast cancer tissues
XIA Xiang-hou;GU Jun-chao;DU Song-tao;XUE Rong-quan Department of General Surgery;Beijing Friendship Hospital;Capital Medical University;Beijing 100050;P.R.China

..............page:1598-1602

Effects of fibroblast cells on tumor growth and metastasis of lung cancer in athymic mouse
ZHU Yun-kui;YANG Na;YAN Jiang-tao;LI Ji-dong;ZHANG Dong-quan;FAN Hong-yan Department of Respiratory Medicine;Lanzhou General Hospital of Lanzhou Military Area Command of PLA;Lanzhou 730005;P.R.China

..............page:1590-1593,1607

Systematic review of the relationship between genetic polymorphism of p73 4G14C-4A14T and the susceptibility to lung cancer
WANG Li;ZHANG Qun;TANG Lin;WEI Feng;NIE Wei-wei;CHEN Long-bang;GUAN Xiao-xiang Department of Oncology;Nanjing General Hospital of Nanjing Military Area;Medical College of Nanjing University;Nanjing 210002;P.R.China

..............page:1585-1589

Expression and signif icance of TNF-α and GLUT-1 in patients with non-small cell lung cancer
CAI Hong-xu1;SONG Ping-ping2;ZHANG Bai-jiang2 1.Harrison International Hospital;Hengshui 053000;P.R.China 2.Department of Surgery Ⅵ;Shandong Tumor Hospital;Jinan 250117;P.R.China

..............page:1603-1607

Meta-analysis of relationship between lymph node micrometastasis and prognosis in patients with esophageal squamous cell carcinoma
FU Yuan-fa;SHEN Gang;TU Jian-jun Department of Surgery;People’s Hospital of Kaihua County;Kaihua 324300;P.R.China

..............page:1616-1619

Maintenance therapy in advanced non-small cell lung cancer
CHENG Ting-ting;YANG Jin Department of Medical Oncology;First Affiliated Hospital of Xi’an Jiaotong University;Xi’an 710061;P.R.China

..............page:1651-1655

zhong hua zhong liu fang zhi za zhi gao yue

..............page:1661-1662

Effect of RNA interference targeting STAT3 on the proliferation and invasion of gastric cancer cell
GONG Fu-sheng;ZHENG Qiu-hong;WANG Xiang-ru;XU Yang-mei Staff Room of Molecular Organism;Teaching Hospital of Fujian Medical University;Fuzhou 350014;P.R.China

..............page:1594-1597

Effects of IFN-γ and IL-4 on the growth and the estrogen receptor subtypes of breast cancer cell MCF-7
NIU Xiu-long;MAO Li-qun;YE Lu;WANG Yue Medical College of Chinese People’s Armed Police Forces;Tianjin 300162;P.R.China

..............page:1581-1584

Lentinan for treatment of malignant pleural effusion:A meta-analysis of randomized controlled trials
FENG Dan;LIU Jia-li;XU Chong-an Department of Oncology;Fourth Affiliated Hospital;China Medical University;Shenyang 110032;P.R.China

..............page:1620-1623